The epidermal growth factor receptor (EGFR) pathway is a crucial signaling pathway in NSCLC, and the discovery of EGFR mutations as the most significant oncogenic driver genes in NSCLC has revolutionized the treatment paradigm for patients with advanced NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.